Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Viral

Rubella

风疹

Rubella is an acute viral illness caused by rubella virus and classically associated with fever and rash [1]. It is often clinically mild, but infection in early pregnancy can lead to congenital rubella syndrome, a condition with serious medical and public-health consequences [1]. Source-backed detail on the full spectrum of population burden is limited here, although WHO estimates cited in the source place congenital rubella syndrome at approximately 100,000 cases per year [1].

Definition

Rubella is a viral disease caused by rubella virus and described as an acute illness, historically also called German measles [1][2]. The source characterization emphasizes a febrile rash illness with the potential for congenital infection when primary maternal infection occurs in early pregnancy [1]. Rubella is therefore relevant both as an individual viral exanthem and as a preventable cause of congenital disease [1].

Clinical features

The typical clinical picture is a mild, self-limited illness with fever, a generalized erythematous maculopapular rash, and lymphadenopathy [1]. A substantial proportion of infections are asymptomatic, with the source estimating this at 25-50% [1]. Reported complications include arthralgia, arthritis, thrombocytopenic purpura, and encephalitis [1]. Congenital rubella syndrome is associated with cataracts, sensorineural hearing impairment, congenital heart disease, jaundice, purpura, hepatosplenomegaly, and microcephaly [1].

Epidemiology

The source notes that congenital rubella syndrome remains a major public-health concern, with WHO estimating approximately 100,000 cases per year [1]. Rubella vaccination coverage was reported at 70% globally in 2020, indicating incomplete population-level protection in the source material [1]. The available snippets do not provide detailed country-specific incidence patterns, seasonality, or outbreak geography, so those data are not yet available from the provided evidence [1].

Transmission

Rubella virus is transmitted through respiratory droplets and direct contact [1]. The provided material does not further define the relative importance of these routes, environmental persistence, or the duration of infectiousness, so source-backed detail beyond these routes is not yet available [1].

Risk groups

The clearest source-defined high-risk group is pregnant people with primary rubella infection in early pregnancy, because this exposure can result in congenital rubella syndrome [1]. The material also indicates that asymptomatic infection is common, which complicates recognition of cases in the wider population [1]. No additional risk-group stratification is supported by the supplied snippets, so further subgroup detail is not yet available [1].

Prevention

Rubella and congenital rubella syndrome can be prevented by rubella-containing vaccines, which are commonly given in combination with measles vaccine [1]. The provided sources also note that public debate and reduced vaccination coverage in some settings have persisted despite the vaccine’s accepted effectiveness [3]. No source-backed details are available here on schedule, catch-up strategy, or other exposure-control measures [1][3].

Surveillance note

In surveillance terms, rubella should be interpreted not only as a usually mild febrile rash illness but also as a marker of preventable congenital risk [1]. Because a large fraction of infections may be asymptomatic, case counts may underrepresent circulation in the population [1]. Monitoring should therefore consider both acute rubella and congenital rubella syndrome burden, while recognizing that the provided sources do not supply further operational surveillance guidance [1].

References
  1. 1 Winter AK et al. Rubella. Lancet. 2022 Apr 2. PMID: 35367004. doi: 10.1016/S0140-6736(21)02691-X. PubMed: https://pubmed.ncbi.nlm.nih.gov/35367004/
  2. 2 Rubella. Clinical Neurovirology. 2020. doi: 10.1201/9781315113913-23. DOI: https://doi.org/10.1201/9781315113913-23
  3. 3 Di Pietrantonj C et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22. PMID: 34806766. doi: 10.1002/14651858.CD004407.pub5. PubMed: https://pubmed.ncbi.nlm.nih.gov/34806766/
  4. 4 Gidengil C et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine. 2021 Jun 23. PMID: 34049735. doi: 10.1016/j.vaccine.2021.03.079. PubMed: https://pubmed.ncbi.nlm.nih.gov/34049735/
  5. 5 German Measles and German Measles in Pregnancy. Archives of Pediatrics & Adolescent Medicine. 1957. doi: 10.1001/archpedi.1957.02060040557010. DOI: https://doi.org/10.1001/archpedi.1957.02060040557010
  6. 6 German Measles. Encyclopedia of Autism Spectrum Disorders. 2021. doi: 10.1007/978-3-319-91280-6_300749. DOI: https://doi.org/10.1007/978-3-319-91280-6_300749
Coding Register
ICD-10
B06
ICD-11
KA63
Key Statistics
Total cases
276K
Total deaths
7
Peak month
2011-05
Coverage
9 reporting countries · 2000-01-01 → 2026-06-20

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
2,275
Data Version
2026-06-20
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
CH
Switzerland FOPH IDDweeklyrest_api

Switzerland

Switzerland FOPH/BAG IDD mandatory reporting API normalized to national case rows. Monthly series may use the dashboard CHFL aggregate where CH-only monthly series are not exposed.

Official source
CN
China CDC WeeklyMONTHLYweb

China

Monthly notifiable infectious disease reports published by China CDC.

Official source
CN
National Disease Control and Prevention AdministrationMONTHLYweb

China

Official China public health bulletin and query portal.

Official source
CN
PubMedMONTHLYweb

China

Biomedical literature discovery feed used as supplementary context.

Official source
HK
Hong Kong, China CHP Notifiable Diseasesmonthlyopen_data_csv

Hong Kong, China

Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
KR
Korea KDCA EIDmonthlyopen_api_or_portal_download

South Korea

Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.

Official source
NZ
phf_monthlymonthlyweb

New Zealand

PHF Science (formerly ESR) monthly notifiable disease surveillance data via internal globalID2 crawler

Official source
TW
Taiwan, China CDC NIDSSmonthlyopen_data_csv

Taiwan, China

Taiwan, China monthly notifiable infectious disease open-data CSV feed.

Official source
US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.